Integra Life Sciences Holdings Corporation was founded in Shanghai has announced the first Asian office to grasp the world's fastest-growing medical devices and the opportunity of market.
As the world's leading neurosurgery medical equipment suppliers, Integra good at regenerative medicine field, with its patent technology to produce collagen matrix surgical implanted device.China waterproof thermometer Integra provide the market diversification of neurosurgery, nerve monitoring, nerve trauma and related intensive care implanted device, instrument, equipment and systems. At the same time, Integra also provide orthopaedic products, including full, ankle, hands, wrists, shoulder, elbow, tendons and peripheral nerves protect and repair,China fever thermometer manufacturer wound healing and spine of equipment and implanted device.
"With the rapid development of Chinese economy,China baby thermometer manufacturer Chinese medical equipment market holds enormous potential for the growth of Integra, provides an important turning point. The establishment of the new office is in the history of the company and an important milestone,China wrist blood pressure monitor and fully embodies the Chinese market for our great attention." Integra chief executive Stuart Essig said.
Integra the greater China region WuJinTai general manager in the China has more than 20 years of international medical equipment company business experience, he said: "early team have five employees, China forehead thermometer our goal is to establish a perfect distribution network,China electronic thermometer manufacturer for China's clients with quality services."
Integra Latin America, asia-pacific and Canada JoAnneHarla vice President, said: "in China, set up the office will help the company in local market rapid development, help us for this important market to provide better services for more patients, bring innovation of medical solution." He also revealed: "at the initial stage, we mainly focus on neurosurgery business, future plans will further into backbones and bone bioactive materials and expand our current orthopaedic product business."